COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence.
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence in Prague, Czech Republic. The innovative medical device offers hope for the estimated 400 million patients affected worldwide -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Affluent Medical : Performance exceptionnelle de la valve Epygon à un an et reconnaissance croissante du concept de valve mitrale biomimétique.
Affluent Medical présente les résultats exceptionnels de la valve mitrale Epygon à un an et la reconnaissance croissante de son concept biomimétique par la communauté médicale -
COMMUNIQUÉ DE PRESSE
Affluent Medical : Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve.
Affluent Medical reports excellent valve performance and increasing recognition of Epygon biomimetic mitral valve, as published in a peer-reviewed journal. The innovative device aims to enhance cardiac performance and patient outcomes -
COMMUNIQUÉ DE PRESSE
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.24.
Affluent Medical communique le nombre d'actions et de droits de vote au 31/01/24 conforme aux réglementations. La société développe des implants innovants pour le traitement des maladies cardiaques et de l'incontinence urinaire -
COMMUNIQUÉ DE PRESSE
Affluent Medical closes €3.5 million bridge via capital increase from key shareholders.
Affluent Medical closes €3.5 million bridge via capital increase from key shareholders. The transaction enables the company to continue exploring options for securing long-term financing and executing critical milestones. The bridge financing extends financial runway until May 2024 without impacting operational activities
